Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2025-03-13 Sale | 2025-03-17 4:09 pm | VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Chief Scientific Officer | 3,231 | $510 | $1,647,810 | 23,281 (Direct) | View |
| 2025-03-10 Sale | 2025-03-12 4:11 pm | VERTEX PHARMACEUTICALS INC | VRTX | WAGNER CHARLES F JR EVP & Chief Financial Officer | 3,298 | $500 | $1,649,000 | 51,671 (Direct) | View |
| 2025-03-10 Sale | 2025-03-12 4:10 pm | VERTEX PHARMACEUTICALS INC | VRTX | Tatsis Ourania EVP, Chief Reg. & Quality Off. | 3,242 | $499.99 | $1,620,968 | 51,239 (Direct) | View |
| 2025-03-10 Sale | 2025-03-12 4:08 pm | VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Chief Scientific Officer | 3,231 | $500 | $1,615,500 | 26,512 (Direct) | View |
| 2025-03-04 Sale | 2025-03-06 4:08 pm | VERTEX PHARMACEUTICALS INC | VRTX | Tatsis Ourania EVP, Chief Reg. & Quality Off. | 4,058 | $485.49 | $1,970,118 | 54,481 (Direct) | View |
| 2025-03-03 Sale | 2025-03-05 4:08 pm | VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Chief Scientific Officer | 3,231 | $490 | $1,583,190 | 29,743 (Direct) | View |
| 2025-02-27 Sale | 2025-02-28 4:48 pm | VERTEX PHARMACEUTICALS INC | VRTX | Tatsis Ourania EVP, Chief Reg. & Quality Off. | 530 | $475.34 | $251,930 | 58,539 (Direct) | View |
| 2025-02-27 Sale | 2025-02-28 4:36 pm | VERTEX PHARMACEUTICALS INC | VRTX | Atkinson Edward Morrow III EVP, Chief Technical Ops. Off. | 2,650 | $475.34 | $1,259,651 | 19,352 (Direct) | View |
| 2025-02-27 Sale | 2025-02-28 4:23 pm | VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Chief Scientific Officer | 1,272 | $480 | $610,560 | 32,974 (Direct) | View |
| 2025-02-25 Sale | 2025-02-26 4:15 pm | VERTEX PHARMACEUTICALS INC | VRTX | Tatsis Ourania EVP, Chief Reg. & Quality Off. | 354 | $480.95 | $170,256 | 64,031 (Direct) | View |
| 2025-02-25 Sale | 2025-02-26 4:09 pm | VERTEX PHARMACEUTICALS INC | VRTX | Atkinson Edward Morrow III EVP, Chief Technical Ops. Off. | 1,767 | $480.95 | $849,839 | 24,484 (Direct) | View |
| 2025-02-25 Sale | 2025-02-26 4:06 pm | VERTEX PHARMACEUTICALS INC | VRTX | Ambrose Kristen SVP & Chief Accounting Officer | 884 | $480.95 | $425,160 | 9,086 (Direct) | View |
| 2025-02-25 Sale | 2025-02-26 4:04 pm | VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Chief Scientific Officer | 848 | $480.95 | $407,846 | 40,200 (Direct) | View |
| 2025-02-20 Sale | 2025-02-24 4:07 pm | VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Chief Scientific Officer | 1,111 | $480 | $533,280 | 45,019 (Direct) | View |
| 2025-02-18 Sale | 2025-02-19 4:36 pm | VERTEX PHARMACEUTICALS INC | VRTX | Tatsis Ourania EVP, Chief Reg. & Quality Off. | 244 | $455.06 | $111,035 | 67,695 (Direct) | View |
| 2025-02-18 Sale | 2025-02-19 4:28 pm | VERTEX PHARMACEUTICALS INC | VRTX | Biller Jonathan EVP and Chief Legal Officer | 1,657 | $455.06 | $754,034 | 17,606 (Direct) | View |
| 2025-02-18 Sale | 2025-02-19 4:21 pm | VERTEX PHARMACEUTICALS INC | VRTX | Ambrose Kristen SVP & Chief Accounting Officer | 671 | $455.06 | $305,345 | 10,798 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2025-04-15 Option Award | 2025-04-17 4:08 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | Upadhyay Suketu Director | 72 | $497.51 | 1,475 (Direct) | View |
| 2025-04-15 Option Award | 2025-04-17 4:07 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | SACHS BRUCE I Director | 95 | $497.51 | 15,240 (Direct) | View |
| 2025-02-26 Tax Withholding | 2025-02-28 4:52 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | WAGNER CHARLES F JR EVP & Chief Financial Officer | 4,962 | $479.61 | 54,969 (Direct) | View |
| 2025-02-26 Tax Withholding | 2025-02-28 4:48 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | Tatsis Ourania EVP, Chief Reg. & Quality Off. | 4,962 | $479.61 | 58,539 (Direct) | View |
| 2025-02-26 Tax Withholding | 2025-02-28 4:46 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | Sachdev Amit EVP Chief Patient & Ext Af Off | 3,703 | $479.61 | 69,372 (Direct) | View |
| 2025-02-26 Tax Withholding | 2025-02-28 4:43 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | Kewalramani Reshma CEO & President | 14,079 | $479.61 | 105,915 (Direct) | View |
| 2025-02-26 Tax Withholding | 2025-02-28 4:41 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | Bozic Carmen EVP and CMO | 4,962 | $479.61 | 32,669 (Direct) | View |
| 2025-02-26 Tax Withholding | 2025-02-28 4:36 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | Atkinson Edward Morrow III EVP, Chief Technical Ops. Off. | 2,482 | $479.61 | 19,352 (Direct) | View |
| 2025-02-26 Tax Withholding | 2025-02-28 4:31 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | Arbuckle Stuart A EVP, COO | 7,071 | $479.61 | 63,075 (Direct) | View |
| 2025-02-26 Tax Withholding | 2025-02-28 4:24 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | Ambrose Kristen SVP & Chief Accounting Officer | 1,241 | $479.61 | 7,845 (Direct) | View |
| 2025-02-26 Tax Withholding | 2025-02-28 4:23 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Chief Scientific Officer | 5,954 | $479.61 | 32,974 (Direct) | View |
| 2025-02-24 Tax Withholding | 2025-02-26 4:16 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | WAGNER CHARLES F JR EVP & Chief Financial Officer | 3,310 | $483.28 | 59,931 (Direct) | View |
| 2025-02-24 Tax Withholding | 2025-02-26 4:15 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | Tatsis Ourania EVP, Chief Reg. & Quality Off. | 3,310 | $483.28 | 64,031 (Direct) | View |
| 2025-02-24 Tax Withholding | 2025-02-26 4:13 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | Sachdev Amit EVP Chief Patient & Ext Af Off | 2,470 | $483.28 | 73,075 (Direct) | View |
| 2025-02-24 Tax Withholding | 2025-02-26 4:12 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | Kewalramani Reshma CEO & President | 9,386 | $483.28 | 119,994 (Direct) | View |
| 2025-02-24 Tax Withholding | 2025-02-26 4:11 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | Bozic Carmen EVP and CMO | 3,310 | $483.28 | 37,631 (Direct) | View |
| 2025-02-24 Tax Withholding | 2025-02-26 4:09 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | Atkinson Edward Morrow III EVP, Chief Technical Ops. Off. | 1,656 | $483.28 | 24,484 (Direct) | View |
| 2025-02-24 Tax Withholding | 2025-02-26 4:07 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | Arbuckle Stuart A EVP, COO | 4,716 | $483.28 | 70,146 (Direct) | View |
| 2025-02-24 Tax Withholding | 2025-02-26 4:06 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | Ambrose Kristen SVP & Chief Accounting Officer | 828 | $483.28 | 9,086 (Direct) | View |
| 2025-02-24 Tax Withholding | 2025-02-26 4:04 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Chief Scientific Officer | 3,971 | $483.28 | 40,200 (Direct) | View |
| 2025-02-14 Tax Withholding | 2025-02-19 4:38 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | WAGNER CHARLES F JR EVP & Chief Financial Officer | 2,293 | $463.46 | 63,241 (Direct) | View |
| 2025-02-14 Tax Withholding | 2025-02-19 4:36 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | Tatsis Ourania EVP, Chief Reg. & Quality Off. | 2,293 | $463.46 | 67,695 (Direct) | View |
| 2025-02-14 Tax Withholding | 2025-02-19 4:34 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | Sachdev Amit EVP Chief Patient & Ext Af Off | 2,139 | $463.46 | 75,545 (Direct) | View |
| 2025-02-14 Tax Withholding | 2025-02-19 4:33 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | LEIDEN JEFFREY M Executive Chairman | 6,066 | $463.46 | 24,466 (Direct) | View |
| 2025-02-14 Tax Withholding | 2025-02-19 4:31 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | Kewalramani Reshma CEO & President | 6,553 | $463.46 | 129,380 (Direct) | View |
| 2025-02-14 Tax Withholding | 2025-02-19 4:30 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | Bozic Carmen EVP and CMO | 1,912 | $463.46 | 40,941 (Direct) | View |
| 2025-02-14 Tax Withholding | 2025-02-19 4:28 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | Biller Jonathan EVP and Chief Legal Officer | 1,504 | $463.46 | 17,606 (Direct) | View |
| 2025-02-14 Tax Withholding | 2025-02-19 4:26 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | Atkinson Edward Morrow III EVP, Chief Technical Ops. Off. | 1,529 | $463.46 | 27,907 (Direct) | View |
| 2025-02-14 Tax Withholding | 2025-02-19 4:25 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | Arbuckle Stuart A EVP, COO | 2,724 | $463.46 | 74,862 (Direct) | View |
| 2025-02-14 Tax Withholding | 2025-02-19 4:21 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | Ambrose Kristen SVP & Chief Accounting Officer | 564 | $463.46 | 10,798 (Direct) | View |
| 2025-02-14 Tax Withholding | 2025-02-19 4:19 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Chief Scientific Officer | 2,293 | $463.46 | 46,130 (Direct) | View |
| 2025-02-12 Option Award | 2025-02-14 4:21 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | WAGNER CHARLES F JR EVP & Chief Financial Officer | 6,655 | $0 | 65,534 (Direct) | View |
| 2025-02-12 Option Award | 2025-02-14 4:18 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | Tatsis Ourania EVP, Chief Reg. & Quality Off. | 6,211 | $0 | 70,232 (Direct) | View |